Bio-Rad Labs (BIO) Tops Q1 EPS by $1.54
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $296.11 -0.39%
EPS Growth %: -30.7%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -30.7%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of $675.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Delta Air shares slip despite strong outlook, Melius says
- Occidental Petroleum releases Q2 2026 earnings considerations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
